LOS ANGELES--(BUSINESS WIRE)--Cougar Biotechnology, Inc. (OTCBB:CGRB) today announced the appointment of Thomas R. Malley to the Company’s Board of Directors. Mr. Malley brings to Cougar more than 16 years of financial management and securities industry experience with life sciences companies. He recently retired from Janus Capital Management, LLC, where he served as a portfolio manager and securities analyst since 1991. During his tenure at Janus, he concentrated on global biotechnology and pharmaceutical companies. Mr. Malley managed several health care focused funds including the Janus Global Life Sciences Fund, which he managed from its inception in December 1998 until his retirement in May 2007.
